Shahar A, Sharon R, Lorber M, Pollack S
Institute of Allergy, Rambam Medical Center, Haifa.
Harefuah. 1997 May 1;132(9):624-6, 679.
Acquired C1-inhibitor (C1-INH) deficiency has been reported in patients with immunoglobulin abnormalities and lymphoproliferative disorders, and angioedema has appeared simultaneously with the lymphoproliferative disease. We present a 50-year-old woman with acquired C1-INH deficiency and angioedema which preceded by 7 years the diagnosis of malignant mantle cell lymphoma. During the interval she was treated with Danazole and there were no attacks of angioedema. When routine follow-up bone marrow aspiration revealed infiltration of nonspecified lymphoma cells, exploratory laparotomy and splenectomy were performed. A month later Danazol was stopped, C1-INH levels returned to normal and there were no attacks of angioedema. Mantle cell lymphoma consisting of lymphocytes with cytoplasmic IgM-lambda was diagnosed in the excised spleen but chemotherapy was not initiated. 6 months later, a second lymphoproliferative disorder, multiple myeloma IgA kappa, was diagnosed.
在患有免疫球蛋白异常和淋巴增生性疾病的患者中,已有获得性C1抑制物(C1-INH)缺乏的报道,并且血管性水肿与淋巴增生性疾病同时出现。我们报告了一名50岁女性,患有获得性C1-INH缺乏和血管性水肿,在诊断为恶性套细胞淋巴瘤之前7年就已出现血管性水肿。在此期间,她接受了达那唑治疗,未发生血管性水肿发作。当常规随访骨髓穿刺显示有未明确的淋巴瘤细胞浸润时,进行了剖腹探查和脾切除术。一个月后停用达那唑,C1-INH水平恢复正常,未发生血管性水肿发作。在切除的脾脏中诊断出由胞质IgM-λ淋巴细胞组成的套细胞淋巴瘤,但未开始化疗。6个月后,诊断出第二种淋巴增生性疾病,即IgA κ多发性骨髓瘤。